Atecegatran (AR-H067637) is an orally active competitive thrombin inhibitor with a K i of 2-4 nM. AR-H067637 inhibits platelet activation and aggregation by blocking thrombin binding to fibrin and thrombomodulin . Atecegatran demonstrates significant anticoagulant effects in various plasma coagulation assays, with an IC 50 ranging from 93 to 220 nM. Atecegatran can be used in research related to thromboembolic disorders.
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Thrombin
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.